EHRA Premium Access

Permanent atrial fibrillation in HFREF and HFPEF: when and how to control rate?


About the speaker

Professor Dipak Kotecha

University of Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)
26 presentations
0 follower

3 more presentations in this session

The impact of atrial fibrillation in HFREF and HFPEF

Speaker: Professor A. Coats (Coventry, GB)


Is there a role for anti-arrhythmic drugs or catheter ablation?

Speaker: Professor F. Ruschitzka (Zurich, CH)


The mitral valve in patients with AF and HF - Do we need specific therapy?

Speaker: Professor R. Rosenhek (Vienna, AT)


Access the full session

New insights on atrial fibrillation in patients with HFrEF and HFpEF: treatment strategies to optimise outcome

Speakers: Professor D. Kotecha, Professor A. Coats, Professor F. Ruschitzka, Professor R. Rosenhek

About the event


EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Related content

Open Access

ICD Therapy in 2021: Saving lives while reducing shocks.

29 August 2021

This platform is supported by

logo Novo Nordisk